Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
44
APGE Quote, Financials, Valuation and Earnings
Last price:
$67.77
Seasonality move
:
18.06%
Day range:
$65.91 - $70.10
52-week range:
$26.20 - $84.56
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.08x
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
95.24%
Market cap:
$4.7B
Revenue:
--
EPS (TTM):
-$4.32
Earnings Data
Next earnings date for APGE
Mar 02
2026
Most recent earnings per share
-$1.11
Beat by $0.04
(Nov 10/2025)
Consensus Estimate
-$1.15
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
APGE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -$1.13 | -- |
| 03/02/2026 | Q4 | -- | -- | -- | -$1.04 | -- |
| 11/10/2025 | Q3 | -- | -- | -$1.11 | -$1.15 | $0.04 |
| 08/11/2025 | Q2 | -- | -- | -$1.13 | -$1.05 | -$0.08 |
| 05/12/2025 | Q1 | -- | -- | -$0.95 | -$1.19 | $0.24 |
| 03/03/2025 | Q4 | -- | -- | -$1.13 | -$1.07 | -$0.06 |
| 11/12/2024 | Q3 | -- | -- | -$0.86 | -$0.74 | -$0.12 |
| 08/12/2024 | Q2 | -- | -- | -$0.60 | -$0.55 | -$0.05 |
| 05/13/2024 | Q1 | -- | -- | -$0.64 | -$0.65 | $0.01 |
| 03/05/2024 | Q4 | -- | -- | -$0.63 | -$0.55 | -$0.08 |
| 11/13/2023 | Q3 | -- | -- | -$0.41 | -- | -- |
| 08/28/2023 | Q2 | -- | -- | -$0.37 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.25 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.28 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.39 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.04 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.09 | -- | -- |
Apogee Therapeutics, Inc. Earnings Questions
-
How Much did Apogee Therapeutics, Inc. Generate in Revenue Last Quarter?
Apogee Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Apogee Therapeutics, Inc. Beat Earnings Last Quarter?
Apogee Therapeutics, Inc. announced earnings per share of -$1.11 which represents a beat of analyst forecast a -$1.15 per share.
-
Is Apogee Therapeutics, Inc. Profitable?
Apogee Therapeutics, Inc. reported -$400K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Apogee Therapeutics, Inc. EPS Next Year?
Apogee Therapeutics, Inc.'s earnings are forecast to decrease from -$3.30 per share to -$4.20 per share next year representing a decrease of -47.98%.
-
When is Apogee Therapeutics, Inc.'s Earnings Date?
Apogee Therapeutics, Inc.'s next earnings date is March 2, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 29x
Alerts
Sell
17
ICLR alert for Feb 13
ICON plc [ICLR] is up 15.9% over the past day.
Buy
67
CGNX alert for Feb 13
Cognex Corp. [CGNX] is up 0.31% over the past day.
Buy
77
IPGP alert for Feb 13
IPG Photonics Corp. [IPGP] is up 2.47% over the past day.
